William J. Sandborn
CIK 1923805 · See Remarks · last filed 2023-09-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
VTYX price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
662 ENCINITAS BLVD. STE 250
ENCINITAS, CA 92024
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Ventyx Biosciences, Inc. (VTYX) Delisted | See Remarks | 84,483 | $13.99 | $1.18M | -$4.38M | 12 | 2023-09-01 |
Recent Filings · Page 2 of 2
18 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-01 | Ventyx Biosciences, Inc. (VTYX) Delisted | Mixed | — | -$362.0K | EDGAR |
| 2023-05-31 | Ventyx Biosciences, Inc. (VTYX) Delisted | Notice (144) | −10,629 | -$360.1K | EDGAR |
| 2023-05-16 | Ventyx Biosciences, Inc. (VTYX) Delisted | Mixed | −215 | -$126.5K | EDGAR |
| 2023-05-01 | Ventyx Biosciences, Inc. (VTYX) Delisted | Mixed | — | -$396.6K | EDGAR |
| 2023-04-28 | Ventyx Biosciences, Inc. (VTYX) Delisted | Notice (144) | −10,790 | -$394.4K | EDGAR |
| 2023-01-18 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-16 | Ventyx Biosciences, Inc. (VTYX) Delisted | Mixed | — | -$1.42M | EDGAR |
| 2022-05-09 | Ventyx Biosciences, Inc. (VTYX) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.